Health
China starts work on plant for mRNA-based COVID-19 vaccine candidate – media – Reuters
China has begun work on a facility to manufacture its first COVID-19 vaccine candidate that uses messenger RNA (mRNA) technology, even though the candidate is still…
By Reuters Staff
FILE PHOTO: A small shopping basket filled with vials labeled “COVID-19 – Coronavirus Vaccine” is placed on a Chinese flag in this illustration taken November 29, 2020. Picture taken November 29, 2020. REUTERS/Dado Ruvic/Ilustration
BEIJING (Reuters) – China has begun work on a facility to manufacture its first COVID-19 vaccine candidate that uses messenger RNA (mRNA) technology, even though the candidate is still in early-stage clinical trials, state-backed media reported on Monday.
…
-
Business17 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News14 hours agoWilliam Robinson dies aged 89
-
Business15 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business18 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.